CMS Robocall for Testing Fraud The Pittsburgh Post-Gazette warns that a robocall is offering free genetic testing for cancer or heart disease as part of a Medicare scam. For Negotiation President Biden is urging lawmakers to pass legislation to enable Medicare to negotiate drug prices directly with companies, the Washington Post says. Biocept HER2 Assay Gains Coverage Under Medicare Local Coverage Determination for CTC Tests Under the LCD, CTC assays, such as Biocept's, will now be covered to guide targeted treatment decisions for patients with breast and other cancers under certain circumstances. US House Appropriations Committee Seeks 15 Percent NIH Funding Increase for Fiscal 2022 The House committee called for an additional $3.5 billion for all existing NIH institutes and centers, with an increase of no less than 5 percent for each. Could Cost Billions NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars. Apr 22, 2021 Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Mar 31, 2021 Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay Premium Mar 2, 2021 PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment Premium Jan 26, 2021 Genomind Receives Medicare Coverage for Pharmacogenetics Test Jan 20, 2021 CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon Dec 22, 2020 Congress Approves 3 Percent Increase in NIH Budget for Fiscal 2021 Dec 10, 2020 Lucence Obtains CLIA Certification for Palo Alto Lab Dec 3, 2020 Local Coverage Determinations Roundup: Castle Bio Dec 2, 2020 Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement Premium Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Nov 13, 2020 Clinical Genomics Nabs Medicare Coverage for Colorectal Cancer Test as Novitas Revises LCD Nov 6, 2020 Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests Oct 28, 2020 Strata Oncology Receives Medicare Coverage for NGS Test Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 19, 2020 CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon Oct 13, 2020 Palmetto Cease-and-Desist Letter to Reimbursement Expert Raises Questions About Pricing Transparency Premium Oct 8, 2020 Castle Bio Receives Expanded Medicare Coverage for Melanoma Test Oct 5, 2020 Resolution Bio Seeks to Widen Private Payor Coverage Following Lung Cancer Liquid Biopsy Launch Premium Sep 25, 2020 Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test Sep 10, 2020 Two Medicare Contractors Align Coverage for MRD Testing With Palmetto Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.